NEI

Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights

Retrieved on: 
Monday, April 1, 2024
Diagnosis, Civil service commission, Research, AATD, Growth, Akari, C5, Patient, Choroidal neovascularization, Sale, B4, PRV, Mortality, Hot game, Clinical trial, Therapy, Priority review, Safety, NEI, European Commission, ADC, Geographic atrophy, Hematopoietic stem cell transplantation, CNV, Pharmaceutical industry

BOSTON and LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the full year 2023 as well as recent company highlights.

Key Points: 
  • BOSTON and LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the full year 2023 as well as recent company highlights.
  • The combined entity will operate as Akari Therapeutics, Plc, which is expected to continue to be listed and trade on the Nasdaq Capital Market as AKTX.
  • Akari is continuing to recruit patients into the Part A portion of the Phase 3 clinical trial that has treated 10 patients to date.
  • During 2023, Akari also advanced the long-acting version of nomacopan (PASylated nomacopan) into the final stages of pre-clinical development as a treatment for geographic atrophy (GA).

BALTIMORE BRIDGE COLLAPSE AFFECTING RELOCATION

Retrieved on: 
Wednesday, March 27, 2024
NEI, Multimedia, Interstate Highway System, Port, Delays, Interstate 695, Francis Scott Key Bridge, Cargo

OMAHA, Neb., March 27, 2024 /PRNewswire/ -- Early on Tuesday morning, tragedy struck as the Francis Scott Key Bridge in Baltimore, Maryland succumbed to collapse following a collision by the 10,000 container-capacity vessel "Dali" which had lost power while enroute from the U.S. to Colombo, Sri Lanka.

Key Points: 
  • OMAHA, Neb., March 27, 2024 /PRNewswire/ -- Early on Tuesday morning, tragedy struck as the Francis Scott Key Bridge in Baltimore, Maryland succumbed to collapse following a collision by the 10,000 container-capacity vessel "Dali" which had lost power while enroute from the U.S. to Colombo, Sri Lanka.
  • Cargo that was intended for Baltimore will likely be discharged at nearby ports and reach their final destination by landside transportation.
  • The bridge (a part of Interstate 695) offered a key transport link between Washington, Baltimore, Philadelphia, and New York.
  • Delays should be expected on any household goods shipments to/from the Port of Baltimore as well as at nearby ports.

NEI Global Relocation Launches NEI All-Access: A Digital Hub for Global Mobility Leaders

Retrieved on: 
Tuesday, March 26, 2024
NEI, HR, Executive, Policy

OMAHA, Neb., March 26, 2024 /PRNewswire/ -- NEI Global Relocation, a leader in global mobility and relocation services, is proud to announce the launch of NEI All-Access , an exclusive online platform designed for Executives, HR Leaders, and Global Mobility Managers and Specialists.

Key Points: 
  • OMAHA, Neb., March 26, 2024 /PRNewswire/ -- NEI Global Relocation, a leader in global mobility and relocation services, is proud to announce the launch of NEI All-Access , an exclusive online platform designed for Executives, HR Leaders, and Global Mobility Managers and Specialists.
  • NEI All-Access stands out as a critical resource for professionals navigating the complexities of global mobility, offering insights into:
    Strategic Insights and Planning: Discover resources that align global mobility strategies with business objectives, ensuring a cohesive approach to talent management across borders.
  • Professional Empowerment: Engage with materials that foster professional growth and development, enhancing the capabilities of HR and global mobility teams.
  • Trend Spotting and Analysis: Stay ahead of the curve with in-depth analysis on the latest global mobility trends, technologies, and policy changes.

Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit

Retrieved on: 
Tuesday, March 5, 2024
Therapy, DLA Piper, Leukotriene B4, NEI, C5, CNV, OTC, Inflammation, Bayer, Choroidal neovascularization, ADC, Risk, AATD, American depositary receipt, Geographic atrophy, Haematopoietic system, Patient, Autoimmunity, McKinsey & Company, Hot game, LTB4, Cancer, Pharmaceutical industry

Following closing, the company will have an expanded pipeline that contains multiple compelling assets spanning early and late development stages.

Key Points: 
  • Following closing, the company will have an expanded pipeline that contains multiple compelling assets spanning early and late development stages.
  • An assessment of the pipeline is planned, including program prioritization, updated timelines, near-term value creation opportunities, and other considerations.
  • Key highlights of the merger include:
    The merged pipeline features a robust ADC toolkit with novel payload and linker technologies.
  • Goodwin Procter LLP is serving as legal advisor to Akari and DLA Piper LLP is serving as legal advisor to Peak Bio.

Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit

Retrieved on: 
Tuesday, March 5, 2024
Therapy, DLA Piper, Leukotriene B4, NEI, C5, CNV, OTC, Inflammation, Bayer, Choroidal neovascularization, ADC, Risk, AATD, American depositary receipt, Geographic atrophy, Haematopoietic system, Patient, Autoimmunity, McKinsey & Company, Hot game, LTB4, Cancer, Pharmaceutical industry

Following closing, the company will have an expanded pipeline that contains multiple compelling assets spanning early and late development stages.

Key Points: 
  • Following closing, the company will have an expanded pipeline that contains multiple compelling assets spanning early and late development stages.
  • An assessment of the pipeline is planned, including program prioritization, updated timelines, near-term value creation opportunities, and other considerations.
  • Key highlights of the merger include:
    The merged pipeline features a robust ADC toolkit with novel payload and linker technologies.
  • Goodwin Procter LLP is serving as legal advisor to Akari and DLA Piper LLP is serving as legal advisor to Peak Bio.

Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update

Retrieved on: 
Thursday, February 22, 2024
Mental Health, Health, Neurology, Clinical Trials, Pharmaceutical, Biotechnology, Acquisition, PANSS, Blood pressure, KRTX, NEI, FDA, Food, Schizophrenia, PDUFA, Psychiatry, Bristol Myers Squibb, Safety, Psychosis, Therapy, Patient, Congress, Positive, NDA, Pharmaceutical industry

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a general business update.

Key Points: 
  • Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a general business update.
  • Results from the EMERGENT-2 trial published in The Lancet in December 2023.
  • Announced positive results from the Phase 1b Ambulatory Blood Pressure Monitoring trial in schizophrenia in the fourth quarter of 2023.
  • Presented additional data from the EMERGENT program at the 2023 Neuroscience Education Institute (NEI) Congress and the CNS Summit in the fourth quarter of 2023.

Northeast Indiana Launches Project Intake Portal for State Funding Geared Towards Catalyzing Regional Growth

Retrieved on: 
Friday, February 2, 2024
Multimedia, NEI, Quality of life, Legislature, SDC, RDA, Rest, Quality

FORT WAYNE, Ind., Feb. 2, 2024 /PRNewswire/ -- Today, the Northeast Indiana Regional Partnership (NEI), on behalf of the Northeast Indiana Strategic Development Commission (SDC) and the Northeast Indiana Regional Development Authority (RDA), launched a project intake portal to solicit innovative project and programming ideas designed to grow population, wages and credential attainment in the 11-county region of Northeast Indiana.

Key Points: 
  • FORT WAYNE, Ind., Feb. 2, 2024 /PRNewswire/ -- Today, the Northeast Indiana Regional Partnership (NEI), on behalf of the Northeast Indiana Strategic Development Commission (SDC) and the Northeast Indiana Regional Development Authority (RDA), launched a project intake portal to solicit innovative project and programming ideas designed to grow population, wages and credential attainment in the 11-county region of Northeast Indiana.
  • Through the portal at: neindiana.com/sdc groups can submit project ideas for review as a first step to applying for funds.
  • Strategic Development Commission funding recommendations will be made on a rolling basis beginning in the Spring of 2024.
  • It serves as the conduit for at least $30 million in state funding to be deployed in the region annually.

NEI launches its first Alternative Investment Fund with NEI Long Short Equity Fund

Retrieved on: 
Monday, January 22, 2024
Senior, NEI, Alternative investment, Investment, Partnership, ESG, Fund, Risk, Aviso, Security (finance)

The new NEI Fund is sub-advised by Picton Mahoney Asset Management, ("Picton Mahoney") a pioneer in alternative investing in Canada.

Key Points: 
  • The new NEI Fund is sub-advised by Picton Mahoney Asset Management, ("Picton Mahoney") a pioneer in alternative investing in Canada.
  • NEI Long Short Equity Fund brings together Picton Mahoney's expertise in alternative strategies and NEI's expertise in responsible investing.
  • The Fund's investment strategy includes exclusionary screens, ESG integration and stewardship to add an extra layer of risk mitigation to Picton Mahoney's active long short equity strategy.
  • Picton Mahoney has nearly 20 years of experience managing alternative investments, including long short strategies, for various clients and investment funds.

Plug and Play Opens New Medtech Office in Warsaw, Indiana

Retrieved on: 
Wednesday, January 17, 2024
Paragon, University, NEI, SDC, City, Commerce, Orthopedic surgery, Business development, Entrepreneurship, Zimmer Biomet, Medtech, Workforce, Organization, AMETEK, Plug and play, Growth, Renewable energy

The new office will be located in the heart of Warsaw, Indiana, renowned for its thriving medtech ecosystem.

Key Points: 
  • The new office will be located in the heart of Warsaw, Indiana, renowned for its thriving medtech ecosystem.
  • Plug and Play aims to leverage the regional expertise and resources to drive collaboration and accelerate the growth of startups in the medtech sector.
  • Plug and Play's expansion into Warsaw, Indiana supports the vision of Zimmer Biomet to transform Warsaw from the Orthopedic capital to the medtech capital of the world.
  • Brandon Noll, former Vice President of Business Development for NEI, has recently joined Plug and Play as the Director of Indiana.

NANO Nuclear Energy Sponsors Nuclear Energy Institute 2024 Nuclear Financing Summit Held in New York City

Retrieved on: 
Tuesday, January 16, 2024
Nuclear Energy Institute, NEI, Heart, Nuclear energy, Renewable energy

New York, N.Y., Jan. 16, 2024 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. ("NANO Nuclear"), an emerging microreactor and advanced nuclear technology company led by a world-class nuclear engineering team developing proprietary, portable, and clean energy solutions, is pleased to announce that it is a Co-Host Sponsor the upcoming 2024 Nuclear Financing Summit, hosted by the Nuclear Energy Institute (NEI).

Key Points: 
  • New York, N.Y., Jan. 16, 2024 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. ("NANO Nuclear"), an emerging microreactor and advanced nuclear technology company led by a world-class nuclear engineering team developing proprietary, portable, and clean energy solutions, is pleased to announce that it is a Co-Host Sponsor the upcoming 2024 Nuclear Financing Summit, hosted by the Nuclear Energy Institute (NEI).
  • “NEI is delighted to welcome NANO Nuclear as our co-host of the upcoming 2024 Nuclear Financing Summit,” said Maria Korsnick, President and CEO of the Nuclear Energy Institute.
  • Meeting that pledge is going to require innovative companies, like NANO Nuclear, to lead the way.”
    Figure 1 - NANO Nuclear Energy Participates and is a Co-Host Sponsor of Nuclear Energy Institute’s Nuclear Financing Summit 2024, to be held on January 30-31, 2024 in New York City
    “We are truly excited that NANO Nuclear will be sponsoring and participating in the upcoming NEI 2024 Nuclear Financing Summit,” said Jay Jiang Yu, Founder and Executive Chairman of NANO Nuclear Energy.
  • “I am thrilled to be a part of the upcoming NEI Nuclear Financing Summit," said James Walker, Chief Executive Officer of NANO Nuclear Energy.